Fluorouracil Injection, Solution
Product Images NDC 25021-215

2 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fluorouracil (NDC 25021-215). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Flu0n 0001 01)

Structural Formula (Flu0n 0001 01)
Chemical structure of fluorouracil showing its molecular formula C4H3FN2O2 with a fluorine atom attached to the pyrimidine ring.*
FDA Label Image

Package Label – Principal Display Panel – Bottle Label (Flu0n 0001 02)

Package Label – Principal Display Panel – Bottle Label (Flu0n 0001 02)
Fluorouracil Injection, USP 50 mg/mL (2.5 grams per 50 mL) intravenous solution by Sagent Pharmaceuticals. The label highlights that this is a pharmacy bulk package for intravenous use only and not for direct infusion. It includes a caution for cytotoxic agent and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.